↓ Skip to main content

A Phase II, Single-Arm Study of Apatinib and Oral Etoposide in Heavily Pre-Treated Metastatic Breast Cancer

Overview of attention for article published in Frontiers in oncology, February 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A Phase II, Single-Arm Study of Apatinib and Oral Etoposide in Heavily Pre-Treated Metastatic Breast Cancer
Published in
Frontiers in oncology, February 2021
DOI 10.3389/fonc.2020.565384
Pubmed ID
Authors

Nanlin Hu, Anjie Zhu, Yiran Si, Jian Yue, Xue Wang, Jiayu Wang, Fei Ma, Binghe Xu, Peng Yuan

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 11%
Student > Doctoral Student 1 5%
Student > Master 1 5%
Researcher 1 5%
Student > Postgraduate 1 5%
Other 0 0%
Unknown 13 68%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Biochemistry, Genetics and Molecular Biology 1 5%
Business, Management and Accounting 1 5%
Sports and Recreations 1 5%
Medicine and Dentistry 1 5%
Other 0 0%
Unknown 14 74%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 March 2021.
All research outputs
#22,774,430
of 25,387,668 outputs
Outputs from Frontiers in oncology
#15,926
of 22,433 outputs
Outputs of similar age
#483,710
of 557,742 outputs
Outputs of similar age from Frontiers in oncology
#654
of 974 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,433 research outputs from this source. They receive a mean Attention Score of 3.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 557,742 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 974 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.